Scotride MP 2mg/500mg/15mg Tablet SR
Marketer
Adenscot Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Scotride MP 2mg/500mg/15mg Tablet SR
Glycemia-Control 2/500/15 SR tablets combine medications to manage blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, reducing blood sugar. Dosage and duration should strictly follow your physician's instructions. Take with food to minimize stomach discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; then, omit the missed dose. Never double the dose; overdose risks hypoglycemia. Concomitant use with other antidiabetics, alcohol, or skipped meals may cause hypoglycemia. Regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, fractures, and respiratory infections. Inform your doctor of any kidney, liver, or heart conditions before starting. Pregnant or lactating individuals should seek medical counsel. Kidney function tests will be conducted prior to treatment commencement. Limit alcohol consumption as it may amplify side effects.
Uses of Scotride MP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Scotride MP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without crushing, chewing, or breaking it. The Scotride MP 2mg/500mg/15mg Sustained-Release tablet should be taken with a meal.
Common Side effects of Scotride MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Scotride MP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Scotride MP 2mg/500mg/15mg Extended-Release Tablets should be administered with food.
How Scotride MP 2mg/500mg/15mg Tablet SR works:
Scotride MP tablets (2mg/500mg/15mg sustained-release) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-action approach enhances blood sugar management when single or dual medication regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Scotride MP 2mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Scotride MP 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release combination tablet Scotride MP (2mg/500mg/15mg) is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when prescribing the extended-release Scotride MP 2mg/500mg/15mg tablet to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. The medication is contraindicated in patients with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Exercise caution when prescribing the extended-release tablet, Scotride MP 2mg/500mg/15mg, to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Scotride MP 2mg/500mg/15mg extended-release tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Scotride MP 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Scotride MP 2mg/500mg/15mg SR Tablet, ingest it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Scotride MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Category | Medication for diabetes |
3,018 People bought this recently